U.S. Court of Appeals for the Federal Circuit
Biodelivery Scis. Int'l, Inc. v. Aquestive Therapeutics, Inc.
This writing
- Type
- Dissent
- Filed
- Aug. 29, 2019
- Case
- Biodelivery Scis. Int'l, Inc. v. Aquestive Therapeutics, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Newman, Circuit Judge, dissenting. The Patent Trial and Appeal Board, on remand from the Federal Circuit, rejected this Court's remand instruction to implement the Supreme Court's holding in SAS Institute . The Board's action departs from principles of appellate review, and negates the agency's obligations under the America Invents Act. From my colleagues' endorsement of these irregular positions,…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.
Other writings in this case
| Type | Author | Filed |
|---|---|---|
| Opinion | Not attributed | Aug. 29, 2019 |
| Opinion of the Court | Not attributed | Aug. 29, 2019 |